Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

NCT00817219 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00817219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00817219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
December 31, 2011
Enrollment
33 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris